-positions and bearing N-9 sugar moieties, such as ribose, 29-deoxyribose, 39-deoxyribose, 29,39-dideoxyribose or cycloalkyl groups like cyclopentane. The data obtained, MIC and minimal bactericidal concentrations demonstrated that the presence of bulky substituents such as cycloheptyl and cyclooctyl rings on the N 6 -amino, together with a chlorine atom in the 2-position, conferred antibacterial activity against the Gram-positive group with MIC values ranging from 16 to 128 mg l "1 . The intact sugar moiety seemed to be not essential for antimicrobial activity and nucleosides bearing deoxyribose or cyclopentyl groups associated with bulky substituents in N 6 -position showed good antimicrobial properties. Furthermore, N-1 proved to be non-crucial and the 2-chloro-N 6 -cyclooctyl-1-deaza-39-deoxyadenosine and 29,39-dideoxyadenosine compounds were among the more active in the series with an MIC of 32 mg l "1 against Staph. aureus and Strep.
pneumoniae. None of the analogues was active against the two Gram-negative species tested. Hence, adenosine derivatives bearing bulky substituents in the N
INTRODUCTION
Antimicrobial resistance is growing at a fast rate and microorganisms such as methicillin-resistant Staphylococcus aureus (MRSA), staphylococci with decreased susceptibility to vancomycin, multi-drug resistant Gram-negative species and Streptococcus pneumoniae with decreased susceptibility to penicillin and other antibacterials are frequently isolated in both hospital and community settings (ECDC, 2010) . Therefore, there is a growing need for novel antimicrobial agents with new mechanisms of action.
Nucleosides and their analogues are one class of compounds that are largely studied and used as antiviral and anti-tumour agents (Isono, 1988) . Some derivatives show moderate to good activity against specific bacterial strains, although, in the last two decades, studies on antibacterial properties have often been neglected in favour of those relating to antiviral and anti-tumour activity. Some recent experiences, however, have proven the great value of this field of research. For example, complex nucleosides exhibit antibacterial activity by specific inhibition of cell-wall peptidoglycan biosynthesis (Kimura & Bugg, 2003) , certain bacterial enzymes, such as purine nucleoside phosphorylases (Bzowska et al., 2000) , and DNA ligases (Mills et al., 2011) . In particular, adenosine analogues such as cordycepin (Ahn et al., 2000) , 29-amino-29-deoxyadenosine and oxetanocin (Shimada et al., 1986) , formycins (Bzowska et al., 2000) , toyocamycin and its derivatives (Kimura & Bugg, 2003) and some purine derivatives (Tunçbilek et al., 2009) showed biological activity including antibiotic properties. More detailed investigations on the antimicrobial activity of various classes of still untested nucleoside derivatives need to be conducted in order to maximize the potential for developing nucleoside analogues for the treatment of bacterial infections. In this study we present the antibacterial activity of a library of adenosine analogues.
METHODS
MICs and minimum bactericidal concentrations (MBCs) were determined by the broth microdilution method according to the Clinical and Laboratory Standards Institute guidelines (CLSI, 2009) and expressed in mg l
21
. The adenosine analogues tested are shown in Table   1 . Their synthesis and chemical data were previously described (Cristalli et al., 1995; Salvatori et al., 2002; Vittori et al., 2000 Vittori et al., , 2006 Volpini et al., 1998 Volpini et al., , 1999 , while compounds 53 and 54 will be described elsewhere. Stock solutions of the compounds were prepared in DMSO. A test with DMSO alone was included as a negative control and one with the known antibiotic vancomycin against Staph. aureus was used as a positive control. Each experiment was repeated three times. Table 1 . Adenosine analogues used in this study
Cpd, compound; R, replacement/substituent group. Statistical analysis was performed on the antimicrobial activity MIC values by using the Kruskal-Wallis Test and multifactor analysis of variance in the STATGRAPHICS Centurion XV software package. The tested compounds were grouped and ranked based on the various substitutions at different sites. The N 6 -substituted molecules were ranked according to size of the substituent and three main groups were identified: no substituent, substituents with ,5 carbons, and substituents with ¢5 carbons (bulky). The analogues substituted at the 2-position in the adenine moiety were grouped as halogenated, thioalkyl/cycloalkyl-, or alkynyl-substituted compounds. In addition, five groups were ranked based on variations in the sugar moiety: ribose, 29-deoxyribose, 39-deoxyribose, 29-39-deoxyribose and analogues with the cyclopentyl group in place of the ribose.
RESULTS AND DISCUSSION
The data demonstrated that some of the compounds showed good antibacterial activity against all or some of the Gram-positives with MIC values ranging from 16 to 128 mg l 21 (Table 2) . Among the adenosine derivatives 1-18, the presence of a 2-thioalkyl/cycloalkyl group (compounds 4 and 6) conferred antibacterial activity and, in particular, compound 6 proved to be one of the most active towards Staph. aureus (MIC 32-64 mg l
21
). The antibacterial activity of several 2-substituted adenosine analogues has recently been reported by Mills et al. (2011) . This study showed that 2-thio-n-butyl adenosine was an inhibitor of the bacterial NAD + -dependent DNA ligase. In the present work, among the 2-substituted adenosine derivatives, the most active agents of the series were 2-thio-n-pentyladenosine (compound 4) and 2-thio-cyclopentyladenosine (compound 6). The structure of these compounds is very similar to that of the previously reported NAD + -dependent DNA ligase inhibitors. Hence, it is possible to hypothesize that a similar mechanism of action is responsible for their antimicrobial activity.
On the other hand, the presence of halogens (compounds 1 and 2) or of a lipophilic alkynyl chain (compounds 7-11) in the same position led to inactive compounds. Moreover, compounds bearing bulky alkyl or aralkyl chains on the N 6 amino (compounds 15-18) showed antibacterial activity against Strep. pneumoniae (P,0.05). The presence of a chlorine atom in the 2-position led to a derivative that was also active towards Staph. aureus (compound 17, MIC 64 mg l
).
The intact sugar moiety seemed to be non-essential for activity against Strep. pneumoniae, and nucleosides bearing deoxyribose groups associated with bulky substituents in the N 6 -position showed good antimicrobial properties. In particular, the 29-deoxy derivative 21 and the 29,39-dideoxy derivative 31, bearing a 2-chlorine atom and an N 6 -cycloheptyl ring, showed the highest activity in the series. On the other hand, the 39-hydroxy group seemed to be more important for antimicrobial activity; in fact, none of the 39-deoxy derivatives (compounds 24-28) displayed antimicrobial properties.
Furthermore, N-1 proved to be non-crucial as the 2-chloro-N 6 -cyclooctyl-1-deaza-39-deoxyadenosine and 29,39-dideoxyadenosine were among the most active compounds (compounds 44 and 48, MIC 32 mg l 21 against Staph. aureus and Strep. pneumoniae). On the contrary, none of the tested 3-deazaadenosine derivatives showed antibacterial activity, although general conclusions cannot be drawn for this subset of compounds given the limited number available for testing (compounds 50-52, Table 1 ).
When the ribose was replaced by a cyclopentyl group and an N 6 -cyclooctyl substituent was introduced, compounds 53 (R5H) and 54 (R5Cl) were obtained (Table 1) , which showed the highest antibacterial activity against Strep. pneumoniae (MIC 16 mg l 21 , Table 2 ).
In conclusion, the presence of bulky substituents at N 6 -position of the tested compounds led to molecules that showed, in general, good antimicrobial properties (P,0.01). The simultaneous presence of a chlorine atom in the On the other hand, none of the analogues was active against the two Gram-negative species tested (P. aeruginosa and E. coli), with the exception of the well-known derivative 19 (cladribine, 2-chloro-29-deoxyadenosine), which had an MIC of 64 mg l 21 against the E. coli strain.
Adenosine and 1-deazaadenosine derivatives bearing bulky substituents in the N 6 -position may represent good lead compounds for the future discovery of a novel series of antibacterial agents. A combination of substituents in the N 6 -position with selected 2-thioalkyl/cycloalkyl chains could be a strategy to improve the antibacterial activity of this class of nucleosides.
Further studies to determine the mechanism of action of these compounds are necessary to identify their cellular target and to design and synthesize more potent analogues.
